BeOne Medicines (ONC) Change in Inventory (2017 - 2026)
BeOne Medicines (ONC) posted quarterly Change in Inventory of $71.8 million for Q1 2026, up 1901.81% year-over-year from $3.6 million in Q1 2025, and up 1.89% quarter-over-quarter from $70.5 million in Q4 2025.
BeOne Medicines (ONC) Change in Inventory (2017 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Change in Inventory for 10 consecutive years, with $71.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 1901.81% year-over-year to $71.8 million; the TTM figure through Mar 2026 stood at $169.0 million (up 236.34% YoY), while the FY2025 annual figure was $93.2 million, up 1.83% from the prior year.
- Change in Inventory improved to $71.8 million in Q1 2026 per ONC's latest filing, from $70.5 million in the prior quarter.
- Across five years, Change in Inventory topped out at $88.6 million in Q4 2023 and bottomed at -$23.8 million in Q3 2024.
- Historically, Change in Inventory has averaged $26.7 million across 5 years, with a median of $28.6 million in 2022.
- Annual changes were most pronounced in 2024 — Change in Inventory sank 1842.71% — and 2026, when it surged 1901.81%.
- BeOne Medicines' Change in Inventory stood at -$18.9 million in 2022, then soared by 567.6% to $88.6 million in 2023, then declined by 10.38% to $79.4 million in 2024, then dropped by 11.18% to $70.5 million in 2025, then increased by 1.89% to $71.8 million in 2026.
- Business Quant data shows ONC's Change in Inventory at $71.8 million in Q1 2026, $70.5 million in Q4 2025, and $28.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.15 Mn |
| Jun 30, 2026 | 47.15 Mn |
| Mar 31, 2026 | 71.84 Mn |
| Mar 31, 2026 | 71.84 Mn |
| Dec 31, 2025 | 70.51 Mn |
| Dec 31, 2025 | 70.51 Mn |
| Sep 30, 2025 | 28.84 Mn |
| Sep 30, 2025 | 28.84 Mn |
| Jun 30, 2025 | -2.19 Mn |
| Jun 30, 2025 | -2.19 Mn |
| Mar 31, 2025 | -3.99 Mn |
| Mar 31, 2025 | -3.99 Mn |
| Dec 31, 2024 | 79.38 Mn |
| Dec 31, 2024 | 79.38 Mn |
| Sep 30, 2024 | -23.84 Mn |
| Sep 30, 2024 | -23.84 Mn |
| Jun 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | -1.32 Mn |
| Mar 31, 2024 | 37.26 Mn |
| Mar 31, 2024 | 37.26 Mn |